Washington Post Examines Development Of Vaccine For Food Borne Intestinal Illness
The Partnership for Public Service/Washington Post examines how decades of work by Navy scientist Patricia Guerry could lead to "the first vaccine for a food borne intestinal illness that affects hundreds of millions of people worldwide each year."
"The vaccine candidate against the pathogen Campylobacter jejuni, developed by Guerry, her colleagues at the U.S. Naval Medical Research Center in Silver Spring and Canadian scientist Mario Monteiro, successfully protected against infection in monkeys during testing last year and is slated for human clinical trials," the newspaper writes.
According to the Washington Post, an "effective vaccine could potentially save tens of thousands of young lives in developing countries where the pathogen has proved deadly," the newspaper writes. The article includes additional information about how the vaccine was developed (8/24).This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.